Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Number of Procedue Conducted by Type & End-users The global spinal fusion devices market will witness a robust CAGR of 3.83%, valued at $6.86 billion in 2021, expected to appreciate and reach $9.63 billion by 2030, confirms Strategic Market Research. North America has the largest industry size, with a revenue share of over 41% in 2020. Spinal fusion is a surgery in which a surgeon permanently connects two vertebrae in the spine, eliminating motion between them. Spinal fusion generally uses a fluoroscopic C-Arm device, pedicle screws, and anterior interbody cages or spacers. Two types of spinal fusion surgery are performed worldwide – posterolateral gutter fusion and lumbar fusion. Spinal fusion surgeries are frequently performed worldwide. According to a study, 1.62 million spinal surgeries are performed annually in the United States of America. Around 350,000 lumbar interbody fusion surgeries are performed every year in the country. 85.5% of the performed lumbar interbody fusion surgeries were anterior, while the rest were posterior. The first spinal surgery was recorded in the 7th century. In 1908, the first lumbar surgery was performed. Spinal fusion became a common surgical procedure in 1941. In 1985, disc decompression was achieved by partially removing disc material through the skin. In 1986, instruments that were used in eye surgery were redesigned for minimally invasive spine procedures. The first laser spinal surgery was done in 1990, and the precision of the laser used in spinal surgery was improved in 1992. Spinal fusion relieves pain to patients who do not respond well to traditional treatment methods. A patient’s unstable spine can be stabilized by spinal fusion. The procedure could help individuals perform certain activities they could not do before the surgery. It can treat various conditions like scoliosis, degenerative disc, etc., and has a high success rate. Market Drivers - The increasing presence of Spinal Disorders, Emergence of Robotic Spinal Fusion Surgeries The number of patients suffering from spinal disorders increases due to various lifestyle factors like diet and smoking. According to the NCBI, 28.1% of the population in the world suffers from spinal disorders. 53.1% reported lumbar spine disorders, while 27.1% reported cervical spine disorders. The spinal fusion devices segment trend has shifted positively due to a rising geriatric population and an increase in people who suffer from spinal disorders. The increased usage of surgical robots for spinal fusion helps shift the global spinal fusion devices market trends upwards. Surgical robots have a greater success rate when performing minimally invasive surgery, which increases their demand. According to a study, for a minimally invasive transforaminal lumbar interbody fusion, the success rate ranges from 60% to 70%, with 80% of patients satisfied with the procedure. For a MI PLIF (posterior lumbar interbody fusion) procedure, the procedure is 90% to 95% successful. Restraints The high costs of surgery and the instruments hinder the industry growth to a great extent. Spinal fusion surgeries generally cost from $14,000 to $150,000. According to an NCBI study, anterior lumbar interbody fusion costs around $ 76,000, while posterior or transforaminal lumbar interbody fusion costs $ 66,000. The spinal fusion devices have high costs. The need to purchase support instruments for spinal fusion hinders the growth. Opportunities - New Surgery Methods New surgical methods can help boost spine surgery products, spinal non-fusion devices, and spinal fusion devices. Different types of spinal surgeries like posterolateral gutter fusion surgery, PLIF(posterior lumbar interbody fusion) surgery, transforaminal lumbar interbody fusion (TLIF) surgery, anterior/posterior lumbar fusion surgery, and anterior lumbar interbody fusion (ALIF) surgery can be used to treat isthmic spondylolisthesis, spinal stenosis, fractures, and tumors, which are rising in plethora in recent years. According to a study, spinal stenosis affects 8 to 11% of the American population, with 2.4 million Americans expected to be diagnosed with the disease in 2021. Spinal stenosis commonly affects people over 50 years old. Multilevel spinal fusion, minimally invasive spinal fusion and Endoscopic ETDIF can also be possible with the advent of new technology. Market Analysis Of Different Segments Covered in the Report Based on Product Thoracolumbar Devices Anterior Lumbar Plates Pedicle Screw and Rods Others Cervical Fixation Devices Anterior Cervical Plates Hook Fixation Systems Others Interbody Fusion Devices Based on Disease Type Trauma & Fractures Complex Deformity Degenerative Disc Others Based on Surgery Minimally Invasive Spine Surgery Open Spine Surgery Based on End-User Specialty Clinics Hospitals Others Regional Coverage Analysis North America United States of America Canada Rest of North America Europe United Kingdom Spain France Germany Italy Rest of Europe Asia-Pacific India China Japan Rest of Asia-Pacific LAMEA Mexico Argentina Brazil Saudi Arabia South Africa Rest of LAMEA Segments Analysis & Insights Based on the Product, the spinal fusion devices market is categorized into Thoracolumbar, Cervical Fixation & Interbody Fusion devices. The Thoracolumbar devices dominate the spinal fusion devices market with a revenue share of 55%, growing with a CAGR of 4.71%, poised to reach $5.30 Bn by 2030. Thoracolumbar devices are essential in the spinal fusion devices market due to their versatility, stability, adaptability, and positive clinical outcomes. These devices are designed to stabilize & fuse vertebrae in the thoracic & lumbar regions of the spine, treating various conditions such as DDD, spinal deformities, trauma-related injuries, tumours & spinal instability. Thoracolumbar devices are highly adaptable & available in multiple sizes, shapes, and configurations, allowing surgeons to select the most appropriate device based on individual patient needs. Thoracolumbar devices are made from biocompatible materials like titanium or stainless steel, offering excellent strength and durability. The market includes various device categories, including Anterior Lumbar Plates & Pedicle Screws and Rods. Based on the Disease Type, the spinal fusion devices market is categorized into Trauma & Fractures, Complex Deformity, and Degenerative Disc. Degenerative disc disease (DDD) dominates the spinal fusion devices market with a revenue share of 42%, growing with a robust CAGR of 7.2%. The global degenerative disc disease treatment is expected to appreciate and reach $50 Bn by 2030. DDD is a common disease affecting intervertebral discs in the spine, causing symptoms like chronic back pain, stiffness, numbness & reduced mobility. Spinal fusion treatment involves joining two or more vertebrae using bone grafts, implants, or devices to stabilize the spine, reduce pain & improve overall function. DDD dominates the spinal fusion devices market due to its effectiveness, technological advancements, growing aging population, the surge in minimally invasive procedures, and favourable reimbursement policies. Based on the Surgery, the spinal fusion devices market is categorized into Minimally Invasive Spine Surgery & Open Spine Surgery. Minimally invasive spine surgery dominates the spinal fusion devices market with a revenue share of 64%, poised to reach $6.16 Bn by 2030. Minimally invasive spine surgery (MISS) dominates spinal surgery, offering numerous advantages over traditional open surgeries. By using smaller incisions, specialized instruments, and advanced imaging technologies, MISS allows surgeons to access the spine with minimal disruption to surrounding tissues, resulting in reduced tissue trauma, faster recovery, and shorter hospital stays. This approach also reduces the risk of complications, such as infection & postoperative pain, and improves visualization & precision. Technological advancements have made MISS procedures more efficient and accessible, increasing adoption rates and market dominance. Based on the End-users, the spinal fusion devices market is categorized into hospitals, specialty clinics & others. Hospitals dominate the spinal fusion devices market with a revenue share of 63.89%, poised to reach $6.14 Bn by 2030. Hospitals dominate the spinal fusion devices market due to their specialized infrastructure, skilled healthcare professionals, advanced medical technology, collaborative approach, patient access, reimbursement and insurance coverage, and research and development activities. These facilities ensure comprehensive care, patient safety, and improved outcomes for spinal fusion procedures. Based on the Region, North America dominates the spinal fusion devices market with a revenue share of 41%, growing with a CAGR of 3.22%. North America dominates the global spinal fusion devices market due to its advanced healthcare infrastructure, increasing incidence of spinal disorders, technological advancements, favourable reimbursement policies, and robust research and development. The United States observes an annual occurrence of 54 spinal cord injuries per million individuals, leading to a total of 17,810 new cases every year. Furthermore, it is worth noting that approximately 31 Mn individuals experience lower back pain at various stages of their lives in the United States. Spinal non-fusion procedures have increased due to multiple factors such as obesity, a sedentary lifestyle, participation in sports, and injuries resulting from accidents. The region's strong presence in academia and healthcare providers fosters innovation and collaboration, fuelling the demand for the spinal fusion devices market. Spinal Fusion Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 6.86 billion The revenue forecast in 2028 USD 9.63 billion Growth rate CAGR of approximately 3.83% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2028) Segmentation By Product, By Disease Type, By Surgery, By End-User, By Region By Product Cervical Fixation Devices, Thoracolumbar Devices, Interbody Fusion Devices. By Disease Type Degenerative Disc, Complex Deformity, Trauma & Fractures, Others By Surgery Open Spine Surgery, Minimally Invasive Spine Surgery By End-User Hospitals, Speciality Clinics, Others By Region Asia-Pacific North America, Europe, LAMEA Country Scope United States of America, United Kingdom, Italy, Germany, France, Spain, Canada, China, India, Japan, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, etc. Company Usability Profiles Stryker, Xtant Medical Holdings, Inc.Zimmer Biomet, DePuy Synthes (a subsidiary of Johnson & Johnson, Inc.), B. Braun Melsungen AG, Medtronic, NuVasive, Inc., Orthofix Medical, Inc., Globus Medical, ATEC Spine, Inc., SeaSpine, Spinal Elements, Inc., Spine Wave, Inc., Captiva Spine, Inc., Spineology, Inc., Global Spinal Fusion Devices Market Competitive Landscape Analysis The market is moderately competitive. Companies operating in the market use strategies such as mergers & acquisitions, regional expansions, partnerships, new product launches, and collaborations to obtain a substantial market share. Some of the major players in the market are: DePuy Synthes (a subsidiary of Johnson & Johnson, Inc.) SeaSpine Globus Medical Orthofix Medical, Inc. B. Braun Melsungen AG Medtronic NuVasive, Inc. Zimmer Biomet ATEC Spine, Inc. Captiva Spine, Inc. Stryker Spineology Spine Wave, Inc. Spinal Elements, Inc. Xtant Medical Holdings, Inc. Recent Developments On May 2023, The patient-powered, smart spinal fusion device developed by DirectSync Surgical was granted Breakthrough Device Designation by the FDA. The device has been explicitly designed to enhance bone healing and post-operative diagnostics, raising the standard of care for patients suffering from irreversibly debilitating conditions. The FDA's Breakthrough Devices Programme aims to expedite the development & evaluation process of medical devices intended to treat life-threatening diseases. DirectSync Surgical has successfully concluded a Phase II Small Business Innovation Research (SBIR) grant endowed by the National Institutes of Health (NIH). The assignment aimed to facilitate a comparative randomized pre-clinical evaluation of bone growth. The company is in the process of securing financing through a seed round to initiate first-in-human trials. On May 2023, HAPPE Spine recently obtained FDA clearance for its INTEGRATE-C interbody fusion system, driven by the innovative Hydroxyapatite Porous Polyetheretherketone (HAPPE) platform. The described interbody fusion cage is a groundbreaking advancement, as it is the initial product to feature complete integration with both porosity and hydroxyapatite. This integration significantly enhances the healing environment, resulting in improved outcomes. The system is designed to be radiolucent, allowing for clear visibility during both intra-operative and post-operative imaging procedures. HAPPE Spine is currently prioritizing a limited user release to validate the effectiveness of its product through rigorous clinical data analysis. The company specializes in designing and commercializing advanced orthopedic and spinal implants, utilizing its patented HAPPEmaterial platform. On October 2022, Theragen was recently granted a second patent in the United States for its ActaStim-S wearable device, designed to stimulate bone growth in patients undergoing spinal fusion surgery. When connected to the Sync app, the device enables patients to monitor their usage and activity levels and report pain entries. The CEO of Theragen highlights the practical benefits of the patent in comparison to bulky and intrusive devices. They assert that ActaStim-S remains at the forefront of innovation in monitoring compliance and activity levels. On August 2022, Nexus Spine recently introduced its PressON posterior lumbar fixation system, which incorporates rods that exert pressure onto pedicle screws rather than utilizing set screws. This innovative design boasts a reduced size of approximately 25% compared to traditional systems, enabling faster implantation. Moreover, it offers enhanced biomechanical strength and effectively eliminates the issue of set screw loosening. Additionally, it allows the intraoperative fabrication of rods tailored to each patient. PressON is a component of Nexus Spine's expanding portfolio of compliant mechanism-based products, which also feature the flexible Tranquil Ti interbody fusion devices. The system's distinctive design obviates the necessity for rod bending and the discomfort associated with incorrectly bent rods and rod creep, rendering it a noteworthy advancement in non-deformity posterior fixation technologies. On July 2022, Wenzel Spine achieved a successful milestone by conducting the inaugural awake spinal fusion procedure utilizing the VariLift-LX interbody implant. The Less Invasive Spine Surgery (LISS) procedure was completed by Dr. Ahmer K. Ghori, an orthopedic spine surgeon who received training at Harvard. Notably, the surgery was conducted without the use of general anesthesia. This particular device is the sole lumbar interbody fusion device that has received clearance from the FDA, allowing implantation without additional fixation. This innovative approach prioritizes reducing the use of instrumentation and preserving anatomical structures, resulting in decreased post-operative complications. As a result, certain medically suitable cases can be discharged on the same day as the surgery. Various Devices that Key Market Leaders Develop: Name of the Product Function Key Player EXPEDIUM VERSE Spine System Complex Spine Surgeries include spinal fusion in a time- and cost-effective manner. DePuy Synthes (a Johnson & Johnson subsidiary) Aleutian Posterior-Lumbar Interbody System Posterior lumbar interbody fusion (PLIF) surgery Stryker Biomet SpinalPak Non-Invasive Spine Fusion Stimulator System Promotion of healing of the spine after spinal fusion Zimmer Biomet SpinalStim™ Treatment of failed fusion or after spinal fusion surgery Orthofix Medical, Inc. Aesculap Aeos Microscopy for Spinal Fusion B. Braun Melsungen AG Frequently Asked Question About This Report What percentage of spinal fusions are successful? 70% to 90% of all spinal fusion surgeries are successful. How much cost is involved in a spinal fusion surgery? A spinal fusion surgery costs from USD 14,000 to USD 150,000. What is the spinal fusion devices market growth? The global spinal fusion devices market is expected to grow at a compound annual growth rate (CAGR) of 3.83% from 2021 to 2030 to reach USD 9.63 billion by 2030. Which disease type held the highest spinal fusion device market share? The degenerative disc segment has the highest spinal fusion device market share, with a valuation of over 42% in 2020. Which surgery segment led the spinal fusion devices market? The minimally invasive surgery segment led the spinal fusion device market with a revenue share of over 64% in 2020. Which product categories are expected to have the highest growth rate in the market for spinal fusion devices market? The cervical fixation devices are expected to have the highest growth rate in the spinal implants and surgical devices market, with a CAGR of 7.22%. What are the opportunistic areas available for new and existing players in the spinal fusion devices market to enhance their market share? New surgical methods can help new and existing players in the spinal implants and surgical devices market to enhance their market share. How big is the spinal fusion devices market? The global spinal fusion devices market size was $6.86 Bn in 2021 and is predicted to reach $9.63 Bn by 2030, with a CAGR of 3.83% during 2021-2030. . Source http://www.ncbi.nlm.nih.gov/ https://www.nscisc.uab.edu/ https://www.businesswire.com/news/home/20220721005114/en/Wenzel-Spine-Announces-First-Awake-Spinal-Fusion-Using-VariLift%C2%AE-LX https://www.businesswire.com/news/home/20220823005261/en/ System https://www.healio.com/news/orthopedics/20221028/theragen-receives-us-patent-for-spinal-fusion-bone-growth-stimulator https://www.medicaldevice-network.com/news/happe-spine-interbody-fusion-system/ https://www.medicaldevice-network.com/news/fda-directsync-spinal-fusion/ https://www.nscisc.uab.edu/pu-%20Final.pdf https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/minimally-invasive-spinal-fusion https://orthoinfo.aaos.org/en/treatment/minimally-invasive-spine-surgery/ https://my.clevelandclinic.org/health/diseases/16912-degenerative-disk-disease https://bestpractice.bmj.com/topics/en-us/820 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Spinal Fusion Devices Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Spinal Fusion Devices Market 4.2.1 market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 market, by region, 2021-2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 market, By Product, 2021-2030 (USD Million) 4.5 By Disease Type Business Analysis 4.5.1 market, By Disease Type, 2021-2030 (USD Million) 4.6 Surgery Business Analysis 4.6.1 market, By Surgery, 2021-2030 (USD Million) 4.6 End-user Business Analysis 4.6.1 market, By End-user, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. End-user Analysis 5.11.1. Trends in End-user (2014-2020) 5.11.2. Trends in End-user (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Thoracolumbar Devices 7.3.1. Thoracolumbar Devices market, 2021-2030 (USD Million) 7.3.1.1 Anterior Lumbar Plates market, 2021-2030 (USD Million) 7.3.1.2 Pedicle Screw and Rods market, 2021-2030 (USD Million) 7.3.1.3 Others market, 2021-2030 (USD Million) 7.4. Cervical Fixation Devices 7.4.1. Cervical Fixation Devices market, 2021-2030 (USD Million) 7.4.1.2 Anterior Cervical Plates market, 2021-2030 (USD Million) 7.4.1.3 Hook Fixation Systems market, 2021-2030 (USD Million) 7.4.1.4 Others market, 2021-2030 (USD Million) 7.5. Interbody Fusion Devices 7.5.1. Interbody Fusion Devices market, 2021-2030 (USD Million) 8. Market: By Disease Type Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Degenerative Disc 8.3.1. Degenerative Disc market, 2021-2030 (USD Million) 8.4. Complex Deformity 8.4.1. Complex Deformity market, 2021-2030 (USD Million) 8.5. Trauma & Fractures 8.5.1. Trauma & Fractures market, 2021-2030 (USD Million) 8.6. Others 8.6.1. Others market, 2021-2030 (USD Million) 9. Market: By Surgery Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Open Spine Surgery 9.3.1. Open Spine Surgery market, 2021-2030 (USD Million) 9.4. Minimally Invasive Spine Surgery 9.4.1. Minimally Invasive Spine Surgery market, 2021-2030 (USD Million) 10. Market: By End-user Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.4. Hospitals 10.4.1. Hospitals market, 2021-2030 (USD Million) 10.5. Specialty Clinics 10.5.1. Specialty Clinics market, 2021-2030 (USD Million) 10.5. Others 10.5.1. Others market, 2021-2030 (USD Million) 11. Market: Regional Outlook 11.1 North America 11.1.1. North America market, By Product, 2021-2030 (USD Million) 11.1.2. North America market, By Disease Type, 2021-2030 (USD Million) 11.1.3. North America market, by End-user, 2021-2030 (USD Million) 11.1.4. North America market, by Country, 2021-2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. market, By Product, 2021-2030 (USD Million) 11.1.4.1.2. U.S. market, By Disease Type, 2021-2030 (USD Million) 11.1.4.1.3. U.S. market, by End-user, 2021-2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada market, By Product, 2021-2030 (USD Million) 11.1.4.2.2. Canada market, By Disease Type, 2021-2030 (USD Million) 11.1.4.2.3. Canada market, by End-user, 2021-2030 (USD Million) 11.2. Europe 11.2.1. Europe market, By Product, 2021-2030 (USD Million) 11.2.2. Europe market, By Disease Type, 2021-2030 (USD Million) 11.2.3. Europe market, by End-user, 2021-2030 (USD Million) 11.2.4. Europe market, by country, 2021-2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. market, By Product, 2021-2030 (USD Million) 11.2.4.1.2. U.K. market, By Disease Type, 2021-2030 (USD Million) 11.2.4.1.3. U.K. market, by End-user, 2021-2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany market, By Product, 2021-2030 (USD Million) 11.2.4.2.2. Germany market, By Disease Type, 2021-2030 (USD Million) 11.2.4.2.3. Germany market, by End-user, 2021-2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France market, By Product, 2021-2030 (USD Million) 11.2.4.3.2. France market, By Disease Type, 2021-2030 (USD Million) 11.2.4.3.3. France market, by End-user, 2021-2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe market, By Product, 2021-2030 (USD Million) 11.2.4.4.2. Rest of Europe market, By Disease Type, 2021-2030 (USD Million) 11.2.4.4.3. Rest of Europe market, by End-user, 2021-2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific market, By Product, 2021-2030 (USD Million) 11.3.2. Asia Pacific market, By Disease Type, 2021-2030 (USD Million) 11.3.3. Asia Pacific market, by End-user, 2021-2030 (USD Million) 11.3.4. Asia Pacific market, by country, 2021-2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China market, By Product, 2021-2030 (USD Million) 11.3.4.1.2. China market, By Disease Type, 2021-2030 (USD Million) 11.3.4.1.3. China market, by End-user, 2021-2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India market, By Product, 2021-2030 (USD Million) 11.3.4.2.2. India market, By Disease Type, 2021-2030 (USD Million) 11.3.4.2.3. India market, by End-user, 2021-2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan market, By Product, 2021-2030 (USD Million) 11.3.4.3.2. Japan market, By Disease Type, 2021-2030 (USD Million) 11.3.4.3.3. Japan market, by End-user, 2021-2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea market, By Product, 2021-2030 (USD Million) 11.3.4.4.2. South Korea market, By Disease Type, 2021-2030 (USD Million) 11.3.4.4.3. South Korea market, by End-user, 2021-2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC market, By Product, 2021-2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC market, By Disease Type, 2021-2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC market, by End-user, 2021-2030 (USD Million) 11.4. Latin America 11.4.1. Latin America market, By Product, 2021-2030 (USD Million) 11.4.2. Latin America market, By Disease Type, 2021-2030 (USD Million) 11.4.3. Latin America market, by End-user, 2021-2030 (USD Million) 11.4.4. Latin America market, by country, 2021-2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil market, By Product, 2021-2030 (USD Million) 11.4.4.1.2. Brazil market, By Disease Type, 2021-2030 (USD Million) 11.4.4.1.3. Brazil market, by End-user, 2021-2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico market, By Product, 2021-2030 (USD Million) 11.4.4.2.2. Mexico market, By Disease Type, 2021-2030 (USD Million) 11.4.4.2.3. Mexico market, by End-user, 2021-2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America market, By Product, 2021-2030 (USD Million) 11.4.4.3.2. Rest of the Latin America market, By Disease Type, 2021-2030 (USD Million) 11.4.4.3.3. Rest of the Latin America market, by End-user, 2021-2030 (USD Million) 11.5. MEA 11.5.1. MEA market, By Product, 2021-2030 (USD Million) 11.5.2. MEA market, By Disease Type, 2021-2030 (USD Million) 11.5.3. MEA market, by End-user, 2021-2030 (USD Million) 11.5.4. MEA market, by Region, 2021-2030 (USD Million) 12. Competitive Landscape 12.1 DePuy Synthes 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. Product Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. Stryker 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Product Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. Zimmer Biomet 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Product Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. Orthofix Medical, Inc 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Product Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. B. Braun Melsungen AG 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Product Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. Medtronic 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Product Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. NuVasive, Inc 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Product Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. Globus Medical 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Product Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. ATEC Spine, Inc 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Product Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. Captiva Spine, Inc 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Product Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. SeaSpine 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. Product Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. Spinal Elements, Inc 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. Product Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. Spine Wave, Inc 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Product Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.14. Spineology, Inc 12.14.1. Company overview 12.14.2. Financial performance 12.14.3. Product Portfolio Analysis 12.14.4. Business Strategy & Recent Development 12.15. Xtant Medical Holdings, Inc 12.15.1. Company overview 12.15.2. Financial performance 12.15.3. Product Portfolio Analysis 12.15.4. Business Strategy & Recent Development List of Tables (63 Tables) TABLE 1. MARKET, By Product, 2021-2030 (USD Million) TABLE 2. MARKET FOR Thoracolumbar Devices, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Cervical Fixation Devices, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Interbody Fusion Devices, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET, By Disease Type, 2021-2030 (USD Million) TABLE 6. MARKET FOR Degenerative Disc, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Complex Deformity, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Trauma & Fractures, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 11. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Specialty Clinics, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET, BY Surgery, 2021-2030 (USD Million) TABLE 15. MARKET FOR Open Spine Surgery, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Minimally Invasive Spine Surgery, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 18. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA MARKET, By Disease Type, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 22. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 23. EUROPE MARKET, By Product, 2021-2030 (USD Million) TABLE 24. EUROPE MARKET, By Disease Type, 2021-2030 (USD Million) TABLE 25. EUROPE MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 26. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC MARKET, By Disease Type, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 30. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 31. LAMEA MARKET, By Product, 2021-2030 (USD Million) TABLE 32. LAMEA MARKET, By Surgery, 2021-2030 (USD Million) TABLE 33. LAMEA MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 34. DePuy Synthes: COMPANY SNAPSHOT TABLE 35. DePuy Synthes: OPERATING SEGMENTS TABLE 36. Stryker: COMPANY SNAPSHOT TABLE 37. Stryker: OPERATING SEGMENTS TABLE 38. Zimmer Biomet: COMPANY SNAPSHOT TABLE 39. Zimmer Biomet: OPERATING SEGMENTS TABLE 40. Orthofix Medical, Inc: COMPANY SNAPSHOT TABLE 41. Orthofix Medical, Inc: OPERATING SEGMENTS TABLE 42. B. Braun Melsungen AG: COMPANY SNAPSHOT TABLE 43. B. Braun Melsungen AG: OPERATING SEGMENTS TABLE 44. Medtronic: COMPANY SNAPSHOT TABLE 45. Medtronic: OPERATING SEGMENTS TABLE 46. NuVasive, Inc: COMPANY SNAPSHOT TABLE 47. NuVasive, Inc: OPERATING SEGMENTS TABLE 48. Globus Medical: COMPANY SNAPSHOT TABLE 49. Globus Medical: OPERATING SEGMENTS TABLE 50. ATEC Spine, Inc: COMPANY SNAPSHOT TABLE 51. ATEC Spine, Inc: OPERATING SEGMENTS TABLE 52. Captiva Spine, Inc: COMPANY SNAPSHOT TABLE 53. Captiva Spine, Inc: OPERATING SEGMENTS TABLE 54. SeaSpine: COMPANY SNAPSHOT TABLE 55. SeaSpine: OPERATING SEGMENTS TABLE 56. Spinal Elements, Inc: COMPANY SNAPSHOT TABLE 57. Spinal Elements, Inc: OPERATING SEGMENTS TABLE 58. Spine Wave, Inc: COMPANY SNAPSHOT TABLE 59. Spine Wave, Inc: OPERATING SEGMENTS TABLE 60. Spineology, Inc: COMPANY SNAPSHOT TABLE 61. Spineology, Inc: OPERATING SEGMENTS TABLE 62. Xtant Medical Holdings, Inc: COMPANY SNAPSHOT TABLE 63. Xtant Medical Holdings, Inc: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 15 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Spinal Fusion Devices Market, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Spinal Fusion Devices Market, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Disease Type, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By End-user, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Surgery, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 Thoracolumbar Devices to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 17 Hospitals to Witness Higher CAGR in Market for End-user Segment during Forecast Period. Figure 18 Degenerative Disc to Witness Higher CAGR in the Market for Disease Type Segment during Forecast Period. Figure 19 Minimally Invasive Spine Surgery to Witness Higher CAGR in Market for Surgery Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview